Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

LXU Healthcare to distribute Response Biomedical's heart tests in US states:

This article was originally published in Clinica

Executive Summary

Vancouver, Canada-based diagnostics developer Response Biomedical has appointed LXU Healthcare, a medical equipment and specialty devices provider based in West Boylston, Massachusetts, as exclusive distributor of three of its RAMP cardiovascular tests in 19 US states. The assays, analysed by Response's fluorescence-based RAMP reader, detect the presence of troponin I, CK-MB and myoglobin, which enable the rapid diagnosis of various cardiovascular conditions. The agreement also covers the future distribution by LXU of Response's new NT-proBNP test, which is expected to be available at the end of 2006.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT058099

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel